|
gptkbp:instanceOf
|
gptkb:biotechnology
|
|
gptkbp:acquiredBy
|
gptkb:Spatial_Transcriptomics
gptkb:Cartana
ReadCoor
|
|
gptkbp:category
|
gptkb:public_company
life sciences company
|
|
gptkbp:CEO
|
gptkb:Serge_Saxonov
|
|
gptkbp:country
|
gptkb:United_States
|
|
gptkbp:focus
|
single-cell sequencing
spatial genomics
|
|
gptkbp:foundedIn
|
2012
|
|
gptkbp:founder
|
gptkb:Ben_Hindson
gptkb:Kevin_Ness
gptkb:Serge_Saxonov
|
|
gptkbp:headquartersLocation
|
gptkb:Pleasanton,_California,_United_States
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
10x Genomics
|
|
gptkbp:industry
|
gptkb:biotechnology
|
|
gptkbp:IPODate
|
September 2019
|
|
gptkbp:notableClient
|
pharmaceutical companies
academic research institutions
|
|
gptkbp:numberOfEmployees
|
over 1,000
|
|
gptkbp:product
|
gptkb:Chromium_Single_Cell_Platform
gptkb:GemCode_Technology
gptkb:Visium_Spatial_Gene_Expression
|
|
gptkbp:revenue
|
$516.4 million
|
|
gptkbp:stockSymbol
|
gptkb:NASDAQ
gptkb:TXG
|
|
gptkbp:technology
|
bioinformatics
microfluidics
next-generation sequencing
|
|
gptkbp:tradedOn
|
gptkb:NASDAQ:_TXG
|
|
gptkbp:website
|
https://www.10xgenomics.com/
|
|
gptkbp:bfsParent
|
gptkb:Arch_Venture_Partners
gptkb:John_Stuelpnagel
gptkb:Casdin_Capital
gptkb:Pleasanton,_California,_USA
gptkb:New_Enterprise_Associates
|
|
gptkbp:bfsLayer
|
6
|